We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
The Prescribing Medicines in Pregnancy database has now been updated to include the following new entries:
- amifampridine - pregnancy category C
- amphotericin B (liposomal) - pregnancy category B2
- alpelisib - pregnancy category D
- avalglucosidase alfa - pregnancy category B1
- axicabtagene ciloleucel - pregnancy category C
- burosumab - pregnancy category B3
- brexucabtagene autoleucel - pregnancy category C
- casirivimab / imdevimab - pregnancy category B2
- COVID-19 Vaccine - elasomeran - pregnancy category B1
- COVID-19 Vaccine - SARS-CoV-2 rS (NVX-CoV2373) - pregnancy category B1
- esketamine - pregnancy category B3
- fibrinogen / thrombin - pregnancy category B2
- finerenone - pregnancy category D
- inclisiran - pregnancy category B1
- infigratinib - pregnancy category D
- lemborexant - pregnancy category B3
- lurbinectedin - pregnancy category D
- lutetium (177Lu) chloride - pregnancy category X
- molnupiravir - pregnancy category D
- nirmatrelvir - pregnancy category B3
- pegvaliase - pregnancy category D
- regdanvimab - pregnancy category B2
- sacituzumab govitecan - pregnancy category D
- sotrovimab - pregnancy category B2
- ticagrelor - pregnancy category B1
- tisagenlecleucel - pregnancy category C
- vericiguat - pregnancy category D
- vortioxetine - pregnancy category B3
- zanubrutinib - pregnancy category D
The following entries have been amended:
- carbimazole - pregnancy category from C to D
- propylthiouracil - pregnancy category from C to D
- COVID-19 Vaccine - BNT162b2 (mRNA) - change of name: COVID-19 vaccine - tozinameran